Sperti C - Search Results

1

Metastasis to the pancreas from colorectal cancer: is there a place for pancreatic resection?

Sperti C, Pasquali C, Berselli M, Frison L, Vicario G, Pedrazzoli S. Sperti C, et al. Dis Colon Rectum. 2009 Jun;52(6):1154-9. doi: 10.1007/DCR.0b013e31819f7397. Dis Colon Rectum. 2009. PMID: 19581861

2

Role of surgery in the treatment of bilio-pancreatic cancer: the European experience.

Pedrazzoli S, Pasquali C, Sperti C. Pedrazzoli S, et al. Among authors: sperti c. Semin Oncol. 2002 Dec;29(6 Suppl 20):23-30. doi: 10.1053/sonc.2002.37379. Semin Oncol. 2002. PMID: 12577230 Review.

3

Pancreatic resection for metastatic tumors to the pancreas.

Sperti C, Pasquali C, Liessi G, Pinciroli L, Decet G, Pedrazzoli S. Sperti C, et al. J Surg Oncol. 2003 Jul;83(3):161-6; discussion 166. doi: 10.1002/jso.10262. J Surg Oncol. 2003. PMID: 12827684 Review.

4

The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity.

Monti P, Leone BE, Marchesi F, Balzano G, Zerbi A, Scaltrini F, Pasquali C, Calori G, Pessi F, Sperti C, Di Carlo V, Allavena P, Piemonti L. Monti P, et al. Among authors: sperti c. Cancer Res. 2003 Nov 1;63(21):7451-61. Cancer Res. 2003. PMID: 14612545

5

18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma.

Sperti C, Pasquali C, Chierichetti F, Ferronato A, Decet G, Pedrazzoli S. Sperti C, et al. J Gastrointest Surg. 2003 Dec;7(8):953-9; discussion 959-60. doi: 10.1016/j.gassur.2003.09.002. J Gastrointest Surg. 2003. PMID: 14675704

6

Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.

Sperti C, Pasquali C, Pastorelli D, Ferronato A, Decet G, Pedrazzoli S. Sperti C, et al. Acta Biomed. 2003;74 Suppl 2:91-5. Acta Biomed. 2003. PMID: 15055044 Review.

7

F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.

Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Pedrazzoli S. Sperti C, et al. J Gastrointest Surg. 2005 Jan;9(1):22-8; discussion 28-9. doi: 10.1016/j.gassur.2004.10.002. J Gastrointest Surg. 2005. PMID: 15623441

8

Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome.

Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, Davoli C, Navaglia F, Zambon CF, Pasquali C, Venza E, Pedrazzoli S, Plebani M. Fogar P, et al. Among authors: sperti c. Pancreas. 2006 Jan;32(1):22-8. doi: 10.1097/01.mpa.0000188305.90290.50. Pancreas. 2006. PMID: 16340740

9

18-fluorodeoxyglucose positron emission tomography and pancreatic cancer.

Pedrazzoli S, Pasquali C, Sperti C, Chierichetti F. Pedrazzoli S, et al. Among authors: sperti c. Dig Surg. 2005;22(6):467-8; author reply 468-9. doi: 10.1159/000092036. Epub 2006 Mar 16. Dig Surg. 2005. PMID: 16549928 Free article. No abstract available.

10

Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms.

Sperti C, Pasquali C, Fiore V, Bissoli S, Chierichetti F, Liessi G, Pedrazzoli S. Sperti C, et al. Am J Surg. 2006 Jun;191(6):743-8. doi: 10.1016/j.amjsurg.2005.03.042. Am J Surg. 2006. PMID: 16720142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters